Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Morra

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemiaE Morra, G Alimena, M Lazzarino, et al.
European Journal of Haematology|August 1, 1990
Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentationE Morra, M Lazzarino, A Castello, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Therapy of essential thrombocythemia with alpha-interferon: results and prospectsM Lazzarino, A Vitale, E Morra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic featuresM Lazzarino, E Orlandi, M Paulli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapyE Brusamolino, M Lazzarino, E Orlandi, et al.
Internal and Emergency Medicine|November 30, 2007
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinicsF Baudo, F de Cataldo, G Mostarda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's diseaseE Brusamolino, E Orlandi, A Canevari, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Leukemia|February 1, 1996
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantationR A Perego, P Marenco, C Bianchi, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemiaE Morra, G Alimena, M Lazzarino, et al.
European Journal of Haematology|August 1, 1990
Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentationE Morra, M Lazzarino, A Castello, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Therapy of essential thrombocythemia with alpha-interferon: results and prospectsM Lazzarino, A Vitale, E Morra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic featuresM Lazzarino, E Orlandi, M Paulli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapyE Brusamolino, M Lazzarino, E Orlandi, et al.
Internal and Emergency Medicine|November 30, 2007
Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinicsF Baudo, F de Cataldo, G Mostarda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's diseaseE Brusamolino, E Orlandi, A Canevari, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Leukemia|February 1, 1996
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantationR A Perego, P Marenco, C Bianchi, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Pageof 15